Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Cost of alirocumab?

See the DrugPatentWatch profile for alirocumab

Price varies a lot by country, insurer, and whether you have any discounts or assistance. Here’s a general idea for the US:

- List price (rough): about $14,000–$15,000 per year for alirocumab (Praluent), dosed at 75 mg every 2 weeks (can be increased to 150 mg every 2 weeks if needed).
- This works out to roughly $540–$600 per two-week dose, or about $1,100 per month at list price.
- Your actual out-of-pocket depends on your insurance, deductible, and any manufacturer savings programs. Many people pay much less with coverage, and the sponsor offers patient assistance for eligible individuals.

Prices in other countries are typically lower due to price negotiations.

If you’d like a more precise figure, tell me:
- your country
- whether you have insurance and what plan you’re on
- whether you’re using the standard 75 mg or 150 mg dose

I can help estimate your out-of-pocket and point you to cost-saving options.



Other Questions About Alirocumab :

Alirocumab cost in uk? Alirocumab? Alirocumab patent expiration? Alirocumab shortage? Alirocumab cost? Alirocumab + biosimilar in development? Alirocumab us patent expiry?